Sustained Release Orally Disintegrating Tablets (ODTs) Comprising Microparticles to Improve Acceptability in Patients with Dysphagia
The development of patient-centric formulations for patients with dysphagia. Prepared ODTs showed promising-disintegration times(<30s)whilst allowing for sustained release and once-daily dosing.
Sailing Smoothly: Partnering with a CDMO for Liquid-Oral Formulation Development
Liquid-oral formulations, from solutions to syrups, come with their fair share of complexities. Think solubility woes, stability concerns, and taste...
Pre-Formulation
Each molecule comes with its own set of formulation opportunities and challenges. Mikart’s development services include a range of pre-formulation...
Pharmaceutical Development
Mikart’s pharmaceutical formulation development group specializes in developing robust product formulas which can be scaled to commercial-level manufacturing. We start...
Michael Kallelis
Michael Kallelis has spent his career in public and private life science companies where he has successfully implemented commercial and...
Louis Weber
Louis Weber has spent his career within the contract development and manufacturing organization industry working for private, equity owned portfolio...
Gus LaBella
Gus LaBella, director of formulation development at Mikart, has over 30 years of experience in oral dosage form development. He...
Liquids and Suspensions
Oral non-sterile liquid manufacturing options offer a variety of liquid and suspension dosage solutions designed specifically around palatability — progressing...